Physicians' Understanding and Practices of Pharmacovigilance: Qualitative Experience from A Lower Middle-Income Country

Developed countries have established pharmacovigilance systems to monitor the safety of medicines. However, in the developing world, drug monitoring and reporting are facing enormous challenges. The current study was designed to explore the challenges related to the understanding and practices of ph...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of environmental research and public health 2020-03, Vol.17 (7), p.2209
Hauptverfasser: Hussain, Rabia, Hassali, Mohamed Azmi, Ur Rehman, Anees, Muneswarao, Jaya, Hashmi, Furqan
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 7
container_start_page 2209
container_title International journal of environmental research and public health
container_volume 17
creator Hussain, Rabia
Hassali, Mohamed Azmi
Ur Rehman, Anees
Muneswarao, Jaya
Hashmi, Furqan
description Developed countries have established pharmacovigilance systems to monitor the safety of medicines. However, in the developing world, drug monitoring and reporting are facing enormous challenges. The current study was designed to explore the challenges related to the understanding and practices of physicians in reporting adverse drug reactions in Lahore, Pakistan. Through the purposive sampling technique, 13 physicians were interviewed. All interviews were audio-recorded, transcribed verbatim, and analyzed for a thematic content analysis. The thematic content analysis yielded six major themes: (1) Familiarity with medication safety and adverse drug reaction (ADR) concept, (2) Knowledge about pharmacovigilance activities, (3) Practices related to ADR reporting, (4) Barriers impeding ADR reporting, (5) Acknowledgement of the pharmacist's role, and (6) System change needs. The majority of the physicians were unaware of the ADR reporting system; however, they were ready to accept practice changes if provided with the required skills and training. A lack of knowledge, time, and interest, a fear of legal liability, poor training, inadequate physicians' and other healthcare professionals' communication, and most importantly lack of a proper reporting system were reported as barriers. The findings based on emerging themes can be used to establish an effective pharmacovigilance system in Pakistan. Overall, physicians reported a positive attitude towards practice changes, provided the concerned authorities support and take interest in this poorly acknowledged but most needed component of the healthcare system.
doi_str_mv 10.3390/ijerph17072209
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7178000</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2635380233</sourcerecordid><originalsourceid>FETCH-LOGICAL-c418t-8edf51cb386ca172ac3951285f48e12f055dd8fbdca08eeb4120915629a5f76a3</originalsourceid><addsrcrecordid>eNpdkc1vEzEQxS0Eom3gyhFZ4lAuW_yx3vVyqBRFBSoFESR6thx7nDjatYO9m5L_vkYtVctprPFvxn7vIfSOkgvOO_LJ7yDtt7QlLWOke4FOadOQqm4IffnkfILOct4RwmXddK_RCWeMSi7EKbpdbY_ZG69DPsc3wULKow7Whw0uBa-SNqM3kHF0eLXVadAmHvzG9zoY-Ix_Trr3ox79AfDVnz0kD6WPXYoDnuNlvIWEv3tre6iug4kD4EWcwpiOb9Arp_sMbx_qDN18ufq1-FYtf3y9XsyXlampHCsJ1glq1lw2RtOWacM7QZkUrpZAmSNCWCvd2hpNJMC6psUFKhrWaeHaRvMZurzfu5_WA1gD5XHdq33yg05HFbVXz2-C36pNPKiWtpIUx2bo48OCFH9PkEc1-GygLwZAnLJixVNGBCOyoB_-Q3dxSqHIU6zhgkvCOC_UxT1lUsw5gXv8DCXqb6bqeaZl4P1TCY_4vxD5HfHAoB0</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2635380233</pqid></control><display><type>article</type><title>Physicians' Understanding and Practices of Pharmacovigilance: Qualitative Experience from A Lower Middle-Income Country</title><source>PubMed Central Open Access</source><source>MDPI - Multidisciplinary Digital Publishing Institute</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><creator>Hussain, Rabia ; Hassali, Mohamed Azmi ; Ur Rehman, Anees ; Muneswarao, Jaya ; Hashmi, Furqan</creator><creatorcontrib>Hussain, Rabia ; Hassali, Mohamed Azmi ; Ur Rehman, Anees ; Muneswarao, Jaya ; Hashmi, Furqan</creatorcontrib><description>Developed countries have established pharmacovigilance systems to monitor the safety of medicines. However, in the developing world, drug monitoring and reporting are facing enormous challenges. The current study was designed to explore the challenges related to the understanding and practices of physicians in reporting adverse drug reactions in Lahore, Pakistan. Through the purposive sampling technique, 13 physicians were interviewed. All interviews were audio-recorded, transcribed verbatim, and analyzed for a thematic content analysis. The thematic content analysis yielded six major themes: (1) Familiarity with medication safety and adverse drug reaction (ADR) concept, (2) Knowledge about pharmacovigilance activities, (3) Practices related to ADR reporting, (4) Barriers impeding ADR reporting, (5) Acknowledgement of the pharmacist's role, and (6) System change needs. The majority of the physicians were unaware of the ADR reporting system; however, they were ready to accept practice changes if provided with the required skills and training. A lack of knowledge, time, and interest, a fear of legal liability, poor training, inadequate physicians' and other healthcare professionals' communication, and most importantly lack of a proper reporting system were reported as barriers. The findings based on emerging themes can be used to establish an effective pharmacovigilance system in Pakistan. Overall, physicians reported a positive attitude towards practice changes, provided the concerned authorities support and take interest in this poorly acknowledged but most needed component of the healthcare system.</description><identifier>ISSN: 1660-4601</identifier><identifier>ISSN: 1661-7827</identifier><identifier>EISSN: 1660-4601</identifier><identifier>DOI: 10.3390/ijerph17072209</identifier><identifier>PMID: 32218355</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Content analysis ; Data collection ; Developed countries ; Drug stores ; Familiarity ; Health care ; Hospitals ; Interviews ; Knowledge ; Legal liability ; Medical personnel ; Participation ; Pharmacology ; Pharmacovigilance ; Physicians ; Qualitative research ; Research methodology ; Side effects ; Therapeutic drug monitoring</subject><ispartof>International journal of environmental research and public health, 2020-03, Vol.17 (7), p.2209</ispartof><rights>2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2020 by the authors. 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c418t-8edf51cb386ca172ac3951285f48e12f055dd8fbdca08eeb4120915629a5f76a3</citedby><cites>FETCH-LOGICAL-c418t-8edf51cb386ca172ac3951285f48e12f055dd8fbdca08eeb4120915629a5f76a3</cites><orcidid>0000-0002-6502-8464 ; 0000-0001-8183-0855</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7178000/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7178000/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32218355$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hussain, Rabia</creatorcontrib><creatorcontrib>Hassali, Mohamed Azmi</creatorcontrib><creatorcontrib>Ur Rehman, Anees</creatorcontrib><creatorcontrib>Muneswarao, Jaya</creatorcontrib><creatorcontrib>Hashmi, Furqan</creatorcontrib><title>Physicians' Understanding and Practices of Pharmacovigilance: Qualitative Experience from A Lower Middle-Income Country</title><title>International journal of environmental research and public health</title><addtitle>Int J Environ Res Public Health</addtitle><description>Developed countries have established pharmacovigilance systems to monitor the safety of medicines. However, in the developing world, drug monitoring and reporting are facing enormous challenges. The current study was designed to explore the challenges related to the understanding and practices of physicians in reporting adverse drug reactions in Lahore, Pakistan. Through the purposive sampling technique, 13 physicians were interviewed. All interviews were audio-recorded, transcribed verbatim, and analyzed for a thematic content analysis. The thematic content analysis yielded six major themes: (1) Familiarity with medication safety and adverse drug reaction (ADR) concept, (2) Knowledge about pharmacovigilance activities, (3) Practices related to ADR reporting, (4) Barriers impeding ADR reporting, (5) Acknowledgement of the pharmacist's role, and (6) System change needs. The majority of the physicians were unaware of the ADR reporting system; however, they were ready to accept practice changes if provided with the required skills and training. A lack of knowledge, time, and interest, a fear of legal liability, poor training, inadequate physicians' and other healthcare professionals' communication, and most importantly lack of a proper reporting system were reported as barriers. The findings based on emerging themes can be used to establish an effective pharmacovigilance system in Pakistan. Overall, physicians reported a positive attitude towards practice changes, provided the concerned authorities support and take interest in this poorly acknowledged but most needed component of the healthcare system.</description><subject>Content analysis</subject><subject>Data collection</subject><subject>Developed countries</subject><subject>Drug stores</subject><subject>Familiarity</subject><subject>Health care</subject><subject>Hospitals</subject><subject>Interviews</subject><subject>Knowledge</subject><subject>Legal liability</subject><subject>Medical personnel</subject><subject>Participation</subject><subject>Pharmacology</subject><subject>Pharmacovigilance</subject><subject>Physicians</subject><subject>Qualitative research</subject><subject>Research methodology</subject><subject>Side effects</subject><subject>Therapeutic drug monitoring</subject><issn>1660-4601</issn><issn>1661-7827</issn><issn>1660-4601</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><recordid>eNpdkc1vEzEQxS0Eom3gyhFZ4lAuW_yx3vVyqBRFBSoFESR6thx7nDjatYO9m5L_vkYtVctprPFvxn7vIfSOkgvOO_LJ7yDtt7QlLWOke4FOadOQqm4IffnkfILOct4RwmXddK_RCWeMSi7EKbpdbY_ZG69DPsc3wULKow7Whw0uBa-SNqM3kHF0eLXVadAmHvzG9zoY-Ix_Trr3ox79AfDVnz0kD6WPXYoDnuNlvIWEv3tre6iug4kD4EWcwpiOb9Arp_sMbx_qDN18ufq1-FYtf3y9XsyXlampHCsJ1glq1lw2RtOWacM7QZkUrpZAmSNCWCvd2hpNJMC6psUFKhrWaeHaRvMZurzfu5_WA1gD5XHdq33yg05HFbVXz2-C36pNPKiWtpIUx2bo48OCFH9PkEc1-GygLwZAnLJixVNGBCOyoB_-Q3dxSqHIU6zhgkvCOC_UxT1lUsw5gXv8DCXqb6bqeaZl4P1TCY_4vxD5HfHAoB0</recordid><startdate>20200325</startdate><enddate>20200325</enddate><creator>Hussain, Rabia</creator><creator>Hassali, Mohamed Azmi</creator><creator>Ur Rehman, Anees</creator><creator>Muneswarao, Jaya</creator><creator>Hashmi, Furqan</creator><general>MDPI AG</general><general>MDPI</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-6502-8464</orcidid><orcidid>https://orcid.org/0000-0001-8183-0855</orcidid></search><sort><creationdate>20200325</creationdate><title>Physicians' Understanding and Practices of Pharmacovigilance: Qualitative Experience from A Lower Middle-Income Country</title><author>Hussain, Rabia ; Hassali, Mohamed Azmi ; Ur Rehman, Anees ; Muneswarao, Jaya ; Hashmi, Furqan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c418t-8edf51cb386ca172ac3951285f48e12f055dd8fbdca08eeb4120915629a5f76a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Content analysis</topic><topic>Data collection</topic><topic>Developed countries</topic><topic>Drug stores</topic><topic>Familiarity</topic><topic>Health care</topic><topic>Hospitals</topic><topic>Interviews</topic><topic>Knowledge</topic><topic>Legal liability</topic><topic>Medical personnel</topic><topic>Participation</topic><topic>Pharmacology</topic><topic>Pharmacovigilance</topic><topic>Physicians</topic><topic>Qualitative research</topic><topic>Research methodology</topic><topic>Side effects</topic><topic>Therapeutic drug monitoring</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hussain, Rabia</creatorcontrib><creatorcontrib>Hassali, Mohamed Azmi</creatorcontrib><creatorcontrib>Ur Rehman, Anees</creatorcontrib><creatorcontrib>Muneswarao, Jaya</creatorcontrib><creatorcontrib>Hashmi, Furqan</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>International journal of environmental research and public health</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hussain, Rabia</au><au>Hassali, Mohamed Azmi</au><au>Ur Rehman, Anees</au><au>Muneswarao, Jaya</au><au>Hashmi, Furqan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Physicians' Understanding and Practices of Pharmacovigilance: Qualitative Experience from A Lower Middle-Income Country</atitle><jtitle>International journal of environmental research and public health</jtitle><addtitle>Int J Environ Res Public Health</addtitle><date>2020-03-25</date><risdate>2020</risdate><volume>17</volume><issue>7</issue><spage>2209</spage><pages>2209-</pages><issn>1660-4601</issn><issn>1661-7827</issn><eissn>1660-4601</eissn><abstract>Developed countries have established pharmacovigilance systems to monitor the safety of medicines. However, in the developing world, drug monitoring and reporting are facing enormous challenges. The current study was designed to explore the challenges related to the understanding and practices of physicians in reporting adverse drug reactions in Lahore, Pakistan. Through the purposive sampling technique, 13 physicians were interviewed. All interviews were audio-recorded, transcribed verbatim, and analyzed for a thematic content analysis. The thematic content analysis yielded six major themes: (1) Familiarity with medication safety and adverse drug reaction (ADR) concept, (2) Knowledge about pharmacovigilance activities, (3) Practices related to ADR reporting, (4) Barriers impeding ADR reporting, (5) Acknowledgement of the pharmacist's role, and (6) System change needs. The majority of the physicians were unaware of the ADR reporting system; however, they were ready to accept practice changes if provided with the required skills and training. A lack of knowledge, time, and interest, a fear of legal liability, poor training, inadequate physicians' and other healthcare professionals' communication, and most importantly lack of a proper reporting system were reported as barriers. The findings based on emerging themes can be used to establish an effective pharmacovigilance system in Pakistan. Overall, physicians reported a positive attitude towards practice changes, provided the concerned authorities support and take interest in this poorly acknowledged but most needed component of the healthcare system.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>32218355</pmid><doi>10.3390/ijerph17072209</doi><orcidid>https://orcid.org/0000-0002-6502-8464</orcidid><orcidid>https://orcid.org/0000-0001-8183-0855</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1660-4601
ispartof International journal of environmental research and public health, 2020-03, Vol.17 (7), p.2209
issn 1660-4601
1661-7827
1660-4601
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7178000
source PubMed Central Open Access; MDPI - Multidisciplinary Digital Publishing Institute; EZB-FREE-00999 freely available EZB journals; PubMed Central; Free Full-Text Journals in Chemistry
subjects Content analysis
Data collection
Developed countries
Drug stores
Familiarity
Health care
Hospitals
Interviews
Knowledge
Legal liability
Medical personnel
Participation
Pharmacology
Pharmacovigilance
Physicians
Qualitative research
Research methodology
Side effects
Therapeutic drug monitoring
title Physicians' Understanding and Practices of Pharmacovigilance: Qualitative Experience from A Lower Middle-Income Country
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T01%3A42%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Physicians'%20Understanding%20and%20Practices%20of%20Pharmacovigilance:%20Qualitative%20Experience%20from%20A%20Lower%20Middle-Income%20Country&rft.jtitle=International%20journal%20of%20environmental%20research%20and%20public%20health&rft.au=Hussain,%20Rabia&rft.date=2020-03-25&rft.volume=17&rft.issue=7&rft.spage=2209&rft.pages=2209-&rft.issn=1660-4601&rft.eissn=1660-4601&rft_id=info:doi/10.3390/ijerph17072209&rft_dat=%3Cproquest_pubme%3E2635380233%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2635380233&rft_id=info:pmid/32218355&rfr_iscdi=true